Robert Aspbury
Corporate Officer/Principal chez CERTARA, INC.
Fortune : 5 M $ au 30/04/2024
Profil
Robert P.
Aspbury is currently the President-Certara Scientific Software at Certara, Inc. Prior to his current position, he worked as the Vice President-Strategic Solutions at Labcorp Drug Development, Inc. from 2016 to 2019.
He holds a doctorate degree from The University of Liverpool, which he obtained in 1995.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CERTARA, INC.
0,18% | 01/04/2024 | 290 176 ( 0,18% ) | 5 M $ | 30/04/2024 |
Postes actifs de Robert Aspbury
| Sociétés | Poste | Début |
|---|---|---|
| CERTARA, INC. | Corporate Officer/Principal | 01/01/2020 |
Anciens postes connus de Robert Aspbury
| Sociétés | Poste | Fin |
|---|---|---|
| COVANCE INC. | Corporate Officer/Principal | 01/03/2019 |
Formation de Robert Aspbury
| The University of Liverpool | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CERTARA, INC. | Technology Services |
| Entreprise privées | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
